Establishment Labs Holdings Inc. - Common Shares (ESTA) earnings
ESTA earnings moved a median of -0.62% by the close. Quarterly and annual ESTA reports and results, each read against the price at its own news timestamp. Back to the ESTA overview →
35 measured ESTA earnings events.
Where these ESTA earnings landedvs 34 measured ESTA earnings reactions
| Middle 50% of ESTA earnings reactions | -2.89% to +5.28% |
|---|---|
| Median reaction (to close) | -0.62% |
| Measured reactions | 34 |
Point-in-time · zero look-ahead
Half of the 34 ESTA earnings events with a measured close landed between -2.89% and +5.28%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ESTABLISHMENT LABS HOLDI For: Jun 30 | SEC filing · Form 10-Q | -0.87% | — | |
| Establishment Labs® Reports Second Quarter 2026 Financial Results | Press release | +5.69% | -10.65% | |
| Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6 | Press release | +2.63% | -1.14% | |
| Form 10-Q ESTABLISHMENT LABS HOLDI For: Mar 31 | SEC filing · Form 10-Q | +0.35% | -0.10% | |
| Establishment Labs Reports First Quarter 2026 Financial Results | Press release | +2.81% | +15.71% | |
| Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6 | Press release | +0.00% | -3.28% | |
| Form 10-K ESTABLISHMENT LABS HOLDI For: Dec 31 | SEC filing · Form 10-K | -0.09% | -0.96% | |
| Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24 | Press release | -1.28% | +4.42% | |
| Form 10-Q ESTABLISHMENT LABS HOLDI For: Sep 30 | SEC filing · Form 10-Q | +0.08% | +4.14% | |
| Establishment Labs Reports Third Quarter 2025 Financial Results | Press release | +2.95% | +12.24% | |
| Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5 | Press release | -1.06% | +1.88% | |
| Establishment Labs Reports Second Quarter 2025 Financial Results | Press release | +6.67% | -5.91% | |
| Form 10-Q ESTABLISHMENT LABS HOLDI For: Jun 30 | SEC filing · Form 10-Q | +0.10% | -2.90% | |
| Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7 | Press release | +0.44% | -2.64% | |
| Form 10-Q ESTABLISHMENT LABS HOLDI For: Mar 31 | SEC filing · Form 10-Q | -1.78% | -3.94% | |
| Establishment Labs Reports First Quarter 2025 Financial Results | Press release | +0.66% | +0.14% | |
| Establishment Labs to Announce First Quarter 2025 Financial Results on May 7 | Press release | -4.08% | -2.01% | |
| Establishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12 | Press release | -1.36% | -10.03% | |
| Form 10-K ESTABLISHMENT LABS HOLDI For: Dec 31 | SEC filing · Form 10-K | -0.59% | -0.28% | |
| Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26 | Press release | -1.14% | +5.56% | |
| Form 10-Q ESTABLISHMENT LABS HOLDI For: Sep 30 | SEC filing · Form 10-Q | +1.36% | -7.63% | |
| Establishment Labs Reports Third Quarter 2024 Financial Results | Press release | +12.33% | +8.44% | |
| Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7 | Press release | +0.44% | -1.28% | |
| Form 10-Q ESTABLISHMENT LABS HOLDI For: Jun 30 | SEC filing · Form 10-Q | +0.22% | +8.55% | |
| Establishment Labs Reports Second Quarter 2024 Financial Results | Press release | +1.81% | +5.55% | |
| Establishment Labs to Announce Second Quarter 2024 Financial Results on August 6 | Press release | +0.33% | -0.13% | |
| Form 10-Q ESTABLISHMENT LABS HOLDI For: Mar 31 | SEC filing · Form 10-Q | -0.12% | -2.85% | |
| Establishment Labs Reports First Quarter 2024 Financial Results | Press release | -1.88% | +4.49% | |
| Establishment Labs to Announce First Quarter 2024 Financial Results on May 8 | Press release | +0.00% | -1.15% | |
| Form 10-K ESTABLISHMENT LABS HOLDI For: Dec 31 | SEC filing · Form 10-K | +0.76% | +9.96% | |
| Form NT 10-K ESTABLISHMENT LABS HOLDI For: Dec 31 | SEC filing · Form NT | +0.76% | +9.96% | |
| Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28 | Press release | -1.63% | -2.25% | |
| Form 10-Q ESTABLISHMENT LABS HOLDI For: Sep 30 | SEC filing · Form 10-Q | -5.37% | -14.04% | |
| Establishment Labs Reports Third Quarter 2023 Financial Results | Press release | -6.24% | +19.65% | |
| Establishment Labs to Announce Third Quarter 2023 Financial Results on November 7 | Press release | -0.11% | -4.66% |
Keep exploring
More ESTA: analyst actions → · SEC filings → · ESTA overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Syros Pharmaceuticals, Inc. (SYRS) | 307 | +0.51% | 55% |
| Adverum Biotechnologies, Inc. (ADVM) | 306 | 0.00% | 49% |
| Syndax Pharmaceuticals, Inc. (SNDX) | 306 | +0.04% | 51% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 305 | +0.42% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.